Brazil is the largest pharmaceutical market in Latin America and a strategic manufacturing hub regulated by the Brazilian Health Regulatory Agency (ANVISA). Partnering with ANVISA B-GMP CDMO companies enables pharmaceutical and biotech organizations to develop and manufacture drug products in compliance with Brazil’s stringent Good Manufacturing Practices (B-GMP).
Brazilian GMP-compliant CDMOs operate under ANVISA regulations that are closely aligned with international standards, including PIC/S principles, EMA, and WHO guidelines, supporting both domestic commercialization and global market access.
Why Choose ANVISA Brazil B-GMP CDMO Companies?
Brazil offers a unique combination of regulatory rigor, manufacturing capacity, and access to Latin American markets. Companies choose Brazil GMP CDMOs for the following reasons:
- ANVISA B-GMP Compliance: Full adherence to Brazilian GMP standards enforced by ANVISA.
- International Regulatory Alignment: Brazilian GMP regulations align with WHO, EMA, and PIC/S principles.
- Strong Inspection Framework: Extensive experience with ANVISA inspections and GMP certification.
- Established Manufacturing Infrastructure: Capabilities covering APIs, oral solids, sterile products, and biologics.
- Strategic LATAM Access: Brazil serves as a gateway to Latin American pharmaceutical markets.
Key Services Offered by ANVISA B-GMP CDMO Companies
Key services offered by Brazilian GMP CDMOs include:
- Regulatory & GMP Support: ANVISA filings, B-GMP certification, inspections, and compliance strategy.
- API Manufacturing: GMP production of small-molecule APIs and intermediates.
- Drug Product Manufacturing: Tablets, capsules, liquids, semi-solids, and sterile dosage forms.
- Sterile & Aseptic Manufacturing: Injectables, vials, ampoules, and lyophilized products.
- Clinical Trial Manufacturing: GMP supply for Phase I–III clinical studies.
- Commercial Manufacturing: Scalable production for Brazilian and international markets.
- Quality Control & Stability: Analytical testing, release testing, and stability programs.
Advantages of Partnering with Brazil GMP CDMO Companies
Working with an ANVISA B-GMP-compliant CDMO provides several strategic advantages:
- Regulatory Credibility: ANVISA-certified facilities are widely respected across LATAM and beyond.
- Market Access: Local GMP manufacturing supports faster registration in Brazil.
- Cost-Effective Manufacturing: Competitive production costs with high GMP standards.
- Inspection-Ready Operations: Robust quality systems and audit preparedness.
- Growing Biopharma Ecosystem: Increasing investment in biologics and advanced therapies.
ANVISA Brazil B-GMP CDMO Companies
Examples of CDMO companies operating under ANVISA B-GMP include:
- Laboratorio REIG JOFRE: Betalactam antibiotics (FDF) development and manufacturing state-of-the-art facilities. [See CDMO profile]
- Grifols International: Sterile manufacturing solutions (small molecules) in flexible bags, provided by a B-GMP compliant CDMO [See CDMO profile]
- Liof Pharma: Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs. [See CDMO profile]
- Laboratori Alchemia SRL: Our facilities are designed to satisfy production requirements ranging from laboratory scale for synthetically complex products or those which are even unknown in literature, to production levels of several hundred kilograms per year. [See CDMO profile]
- FAES FARMA: Developer and manufacturer of human medicinal products. [See CDMO profile]
- Aenova: Competence Center animal health products and sterile technologies. [See CDMO profile]
- HIPRA BIOTECH SERVICES: End-to-end internal capabilities from cell line development to commercial manufacturing, fully ANVISA B-GMP compliant CDMO. [See CDMO profile]
- Skyepharma: EXPERT AND INNOVATIVE CDMO COMPLEX ORAL SOLIDS: Fully integrated french CDMO Skyepharma is a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. [See CDMO profile]
- CARBOGEN AMCIS: Highly Potent APIs development and small-scale cGMP production including chromatography and lyophilization. [See CDMO profile]
- Darnytsia Kyiv: CMO combining advanced facilities, stringent quality control, and expert staff to deliver reliable, compliant, and innovative solutions for its clients. [See CDMO profile]
- Adare Pharma: Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. [See CDMO profile]
- MENADIONA: Contract development and manufacturing partner located in Spain for APIs, Intermediates and fine chemicals specialized in transferring R&D projects into fully cGMP-compliant manufacturing processes. [See CDMO profile]
- Content Group: Tubilux Pharma: registered office; manufacturing facility fully aligned with ANVISA Brazil B-GMP. [See CDMO profile]
Related Pages
Find the Right ANVISA B-GMP CDMO Partner with MAI CDMO
At MAI CDMO Network, we connect pharmaceutical and biotech companies with trusted ANVISA B-GMP CDMO companies. Whether you require local Brazilian manufacturing, LATAM market entry, or GMP-compliant scale-up, we help identify partners aligned with ANVISA regulatory expectations and global quality standards.
Looking for an ANVISA B-GMP compliant CDMO? Contact us to find the right Brazilian manufacturing partner for your project.